Targeting Parkinson's Disease 2011
June 8 - 9, 2011
Philadelphia PA , Vereinigte Staaten
DISEASE MODIFICATION TARGETS
Translational Control of alpha-Synuclein: New Treatment for Parkinson’s Disease
Targeting Nuclear Hormone Receptors to Treat Neurodegenerative Disease
MOUSE MODELS
Mitopark Mice: A Model of Progressive Dopamine Depletion and Parkinsonism
IMAGING
Animal Model of Presymptomatic Parkinson’s Diseases
BIOMARKERS
Is Modulating Synuclein Phosphorylation a Potential Disease Modifying Approach for Parkinson’s Disease?
TARGETING SYMPTOMS OF PARKINSON’S
Novel mGluR4 Positive Allosteric Modulators in Parkinson’s Disease
Translational Control of alpha-Synuclein: New Treatment for Parkinson’s Disease
Targeting Nuclear Hormone Receptors to Treat Neurodegenerative Disease
MOUSE MODELS
Mitopark Mice: A Model of Progressive Dopamine Depletion and Parkinsonism
IMAGING
Animal Model of Presymptomatic Parkinson’s Diseases
BIOMARKERS
Is Modulating Synuclein Phosphorylation a Potential Disease Modifying Approach for Parkinson’s Disease?
TARGETING SYMPTOMS OF PARKINSON’S
Novel mGluR4 Positive Allosteric Modulators in Parkinson’s Disease
Ort
Location: Sheraton Philadelphia City Center Hotel
Kontaktieren
17th & Race St. Philadelphia , USA
Ähnliche Veranstaltungen
Targeting Parkinson's Disease June 4 - 6, 2013
Targeting Parkinson's Disease 4 June, 2012
Targeting Parkinson's Disease June 8 - 9, 2011